The performance difference between the sexes (in percent) across age groups for split disciplines and overall race times. by Beat Knechtle (5504402)

Subjects:

Participants by event status and sex. by Beat Knechtle (5504402)

Subjects:

S1 Data - by Beat Knechtle (5504402)

Subjects:

Sex difference in swimming by split disciplines by the type of swim, bike, and run course. by Beat Knechtle (5504402)

Subjects:

Average split and overall race times (HH:MM:SS). by Beat Knechtle (5504402)

Subjects:

Split and overall race times for women and by age group. by Beat Knechtle (5504402)

Subjects:

Trends of average and best race times for IRONMAN^® age group triathletes. by Beat Knechtle (5504402)

Subjects:

S2 Data - by Beat Knechtle (5504402)

Subjects:

Number of finishers by sex and men-to-women ratio over the years between 2002 and 2022. by Beat Knechtle (5504402)

Subjects:

Split and overall IRONMAN^® race times histograms for women and men. by Beat Knechtle (5504402)

Subjects:

Men-to-women ratio across age groups. by Beat Knechtle (5504402)

Subjects:

Trend of the sex difference across years in overall race time. by Beat Knechtle (5504402)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

(A) Beta-diversity non-metric multidimensional scaling (NMDS) analysis at genus level, and (B) LEfSe for bacterial species biomarkers representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... by Sonsawan Sangprasert (22772538)

Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate). by Manal A. Alossaimi (10269852)

“…<p>Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).…”

Box plots showing baseline prevalence and mean egg count at pre-MDA1 in districts that were responders compared to those that were persistent hotspots of decreasing praziquantel ef... by Takafira Mduluza (39754)

Comparisons of electrolyte level of <i>H</i>. <i>pylori</i>-infected and non-infected study participants at JMC, 2023 (Mann–Whitney U-Test). by Negussie Sarbecha (20108068)

Subjects:

Comparisons of mean values of lipid profiles of <i>H</i>. <i>pylori</i>-infected and non-infected study participants at Jimma Medical Hospital, 2023. by Negussie Sarbecha (20108068)

Subjects:

Sodium levels in Canadian restaurant menu items compared to UK National Salt Reduction Initiative (NSRI) targets by UK NSRI food category. by Caroline G. Middleton (22041479)

Subjects: